Key result
Challenge tests with citalopram, reboxetine, and bromocriptine discriminate physical from social anhedonia and global depression.
Why the study?
It was unclear if anhedonia and its components Physical and Social Anhedonia show distinct neurochemical response patterns to neurotransmitter challenge tests compared to depression.
Can neurotransmitter challenge tests discriminate between depression, physical anhedonia, and social anhedonia in male volunteers?
RCT (n=36)
Double-blind
Can neurotransmitter challenge tests discriminate between depression, physical anhedonia, and social anhedonia in male volunteers?
Neurochemical response patterns to specific neurotransmitter challenges can discriminate between physical anhedonia, social anhedonia, and global depression.
Answers are grounded in this paper and cite their sources.
May support neurochemical subtyping in depression trials; extends discrimination of physical versus social anhedonia in volunteers.
The aim of this study was to investigate, if anhedonia, a salient component of depression, shows similar response patterns to neurotransmitter challenge tests as depression, and if the two questionnaire based components Physical (PA) and Social (SA) Anhedonia can be discriminated by differences in drug related size and time of cortisol responses elicited by the specific serotonin (5- HT) and noradrenaline (NA) reuptake inhibitors citalopram and reboxetine and prolactin responses to the dopamine (DA) agonist bromocriptine orally applied to 36 male volunteers in a double blind balanced cross-over design. Analyses of variance applied to placebo corrected hormone responses revealed that low and late DA responses were characteristics of global Depression and of Physical Anhedonia, and that low DA responses were associated with high NA responses in PA, and with low 5-HT responses in SA. These patterns were explained by differences in transmitter production and receptor sensitivities and proved to be suitable to discriminate PA from SA and from global depression by analysing neurochemical response patterns rather than single means of variables.
No takes yet. Share an insight, caveat, or question.
Netter et al. (2016) conducted an RCT in Depression and Anhedonia (n=36). Citalopram, reboxetine, and bromocriptine vs. Placebo was evaluated on Cortisol and prolactin responses. Neurotransmitter challenge tests with citalopram, reboxetine, and bromocriptine discriminated physical from social anhedonia and global depression based on neurochemical response patterns.
Synapse has enriched 10 related papers. Consider them for comparative context: